Catalent Pharma Solutions, the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products, today announced that it has acquired the
remaining stake in Redwood Bioscience Inc., and the SMARTag
Antibody-Drug Conjugate (ADC) technology platform.
for Catalent Expands Its Technology Offerings in Biologics, Acquires Redwood Bioscience Inc. and the SMARTag™ Technology Platform investment picks